In any case, the Rossari Biotech Ltd. epitomized in 2009. Positively, the organization came up as a producer of material claim to fame synthetic compounds. Then again, it gives tweaked answers for the clothing and furthermore creature and poultry feed. The organization intends to enter the market through its first sale of stock. The IPO membership period will begin on thirteenth July and it will end on fifteenth July 2020.
Rossari Biotech Ltd. Initial public offering Details:
Offer Period: 13th July to fifteenth July 2020.
Initial public offering Type: Book Built Issue IPO.
Initial public offering Size: 1,16,82,033 Eq Shares of Rs. 2 (totaling up to Rs. 496.49 cr).
Offer for Sale: 1,05,00,000 Eq Shares of Rs. 2 (totaling up to Rs. 500 cr).
Face Value: Rs. 2 for each Equity Share.
Initial public offering Price: Rs. 423 to Rs. 425 Per Equity Share.
Market Lot: 35 Shares.
Least Order Quantity: 35 Shares.
Posting At: BSE, NSE.
The organization presented a 'Book Built Issue IPO' type first sale of stock with the assumed worth of Rs. 10 for each value share. At first, Rossari Biotech gave an issue size of 1,16,82,033 value imparts to a totaling of Rs. 496.49 cr. Likewise, the value band of the issue from Rs. 423 to Rs. 425 for each value share.
The market part and least request amount of the issue is 35 offers for every each. On the off chance that any financial specialist ought to put resources into this organization with a base speculation measure of Rs. 14,875 (1 lot=35 shares). Likewise, the most extreme venture measure of Rs. 1,93,375 (13 lot= 455 offers).
The advertisers of the organization are Mr. Edward Menezes and Mr. Sunil Chari.
Pre-Issue Share Holding: 95.06%.
The object of the organization, it intends to use the IPO raised sum for the working capital necessities, and issue costs. The organization offers will be list on both the National Stock Exchange and Bombay Stock Exchange.
Initial public offering Registrar:
Link Intime India Private Ltd,
C 101, 247 Park, L.B.S.Marg,
Vikhroli (West), Mumbai-400083.
Telephone: +91-22-4918 6270
Disclaimer: This post is only data about the IPO. It doesn't offer any guidance or suggestion. If it's not too much trouble read the offer report cautiously and counsel your guide before contributing.